Overview
Biocam is a company that designs and manufactures an endoscopic capsule for imaging the digestive system, enabling real-time detection of potential threats. They also provide an AI-powered telemedicine platform and a mobile application to assist patients in preparing for the examination. Their technology is aimed at non-invasive gastrointestinal observation and diagnosis of abnormalities and diseases.
Financials
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-08-01. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 30, 2025 | Transformation registered |
Public aid
14 public aid cases recorded, with a total value of $2,796,731.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 14, 2025 | De minimis aid constituting compensation for services of general economic interest (in accordance with Commission Regulation 2023/2832) | $3,516$3,516 | Investin sp. z o.o. | |
| Sep 16, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,444$1,444 | Marszałek Województwa Dolnośląskiego | |
| Sep 5, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,249$1,249 | Investin sp. z o.o. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-04-01 | Kapsułka endoskopowa wyposażona w selektywne moduły oświetleniowe z nowatorskimi elementami sztucznej inteligencji do diagnostyki układu pokarmowego | $1.3M$1,256,425 | Fundusze Europejskie dla Dolnego Śląska 2021-2027 | |
| 2020-10-10 | Przygotowanie wniosku o Eurogrant planowanego do złożenia przez BIOCAM Sp. z o.o. w ramach konkursu Fast Track to Innovation (FTI). | $5,962$5,962 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board – the sole member of the management board acting independently. In the case of a multi-member management board – two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bulletprovesp. z o.o. | $867,545.53 | bulletprove.com | ||
| OrthogetS.A. | $532,980.53 | orthoget.com | ||
| Active Textsp. z o.o. | $409,418.80 | active-text.pl | ||
| DigitmedS.A. | $382,907.91 | digitmed.pl | ||
| BiottsS.A. | $372,115.60 | biotts.com | ||
| MedisensonicS.A. | $362,572.63 | medisensonic.com | ||
| PolbionicaS.A. | $356,011.70 | polbionica.com | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-20 | Share capital change (209,600.00 PLN → 240,619.50 PLN) | |
| 2025-12-03 | Share capital change (201,600.00 PLN → 209,600.00 PLN) | |
| 2025-04-18 | Entered in the register |
FAQ
Last updated: 2026-07-09